PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 16, 2026Case Reports in Rheumatology0 citationsOpen Access

A Case of Pseudogout in an Adolescent on Isotretinoin

View Full Paper
TKToshihide KuroeTWTayyaba WajihNONarihan Osman

Key Points

  • This case report aims to highlight the occurrence of pseudogout in a young patient on isotretinoin.
  • Description of a case involving an adolescent patient
  • Assessment of acute pain in the left upper extremity
  • Analysis of synovial fluid for crystal identification
  • Patient presented with acute left upper extremity pain and weakness
  • Birefringent calcium pyrophosphate dihydrate crystals were identified in synovial fluid
  • Symptoms resolved after discontinuing isotretinoin

Abstract

Pseudogout or calcium pyrophosphate dihydrate deposition disease rarely occurs in the young. Known risk factors for pseudogout include age, previous surgery, trauma, metabolic conditions, and medications. Isotretinoin, a retinoid frequently used to control acne vulgaris, is known to cause arthralgia, arthritis, and myalgia. We describe a case of an adolescent using isotretinoin who presented with acute left upper extremity pain and weakness. Birefringent calcium pyrophosphate dihydrate crystals were seen on synovial fluid analysis. The patient’s symptoms resolved after discontinuing isotretinoin. This is the first reported case of pseudogout in an adolescent on isotretinoin.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Kuroe et al. (2026) studied this question.

synapsesocial.com/papers/699264d1eb1f82dc367a0c1fhttps://doi.org/10.1155/crrh/7179310
Ask AI
Helpful
Bookmark
Share
View Full Paper